Product
9MW3011
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Single-center, Randomized, Double-Blind, Placebo-Controlled Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity Characteristics of 9MW3011 in Healthy VolunteersStatus: Active (not recruiting), Estimated PCD: 2024-04-01